LoquiÑo, Jasmine .

HRN: 22-52-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2025
CEFTRIAXONE 1G (VIAL)
07/26/2025
08/02/2025
IV
2gms
Q24
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: